We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $303B Turnover 20.41%
1-Year Est. Return 53.02%
 

Citigroup is a multinational investment bank and financial services company, formed in 1998 when Citicorp, the holding company for Citibank, merged with Travelers. Citibank dates to 1812, when it was chartered as City Bank of New York to serve a group of local merchants. In 2009 it merged its Smith Barney brokerage and wealth unit with Morgan Stanley's into a joint venture, and in 2013 it sold its remaining stake to Morgan Stanley. Its businesses cover investment, corporate and commercial banking, sales and trading in the markets, cash management and trade finance for companies, wealth management, and credit cards in the United States.

This Fund
S&P 500
This Quarter Est. Return
+32.49%
1 Year Est. Return
+53.02%
3 Year Est. Return
+141.18%
5 Year Est. Return
+166.47%
10 Year Est. Return
+608.47%
AUM
$303B
AUM Growth
+$68.2B
Cap. Flow
+$27.6B
Cap. Flow %
9.12%
Top 10 Hldgs %
20.13%
Holding
6,442
New
555
Increased
3,283
Reduced
1,427
Closed
760
Avg Time Held Equity + Options
6.8 years
Top 10 Avg Time Held Equity + Options
2 years
Top 20 Avg Time Held Equity + Options
2.6 years
Avg Time Held Equity only
7.3 years
Top 10 Avg Time Held Equity only
3.9 years
Top 20 Avg Time Held Equity only
3.4 years

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.36B
2
TSLA icon
Tesla
TSLA
+$1.09B
3
AMZN icon
Amazon
AMZN
+$1B
4
MSFT icon
Microsoft
MSFT
+$963M
5
AAPL icon
Apple
AAPL
+$864M

Sector Composition

Rank Sector Weight
1 Miscellaneous 39.44%
2 Technology 25.75%
3 Financials 6.27%
4 Consumer Discretionary 5.79%
5 Industrials 5.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DLX icon
3651
Deluxe
DLX
$1.01B
$671K ﹤0.01%
28,091
-28,679
-51% -$746K
2013 Q2
52 quarters
VAW icon
3652
Vanguard Materials ETF
VAW
$3.28B
$669K ﹤0.01%
2,922
-421
-13% -$97.7K
2013 Q2
52 quarters
PAHC icon
3653
Phibro Animal Health
PAHC
$1.53B
$668K ﹤0.01%
21,275
-49,592
-70% -$2.09M
2014 Q2
48 quarters
MYGN icon
3654
Myriad Genetics
MYGN
$578M
$667K ﹤0.01%
116,820
+99,813
+587% +$453K
2013 Q2
52 quarters
XOVR icon
3655
EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF
XOVR
$1.41B
$666K ﹤0.01%
+31,649
New +$604K
2026 Q2
0 quarters
PZZA icon
3656
Papa John's
PZZA
$611M
$665K ﹤0.01%
18,081
+9,659
+115% +$333K
2013 Q2
52 quarters
EXK icon
3657
Endeavour Silver
EXK
$2.08B
$664K ﹤0.01%
80,030
+60,468
+309% +$563K
2024 Q2
8 quarters
AHRT icon
3658
AH Realty Trust
AHRT
$477M
$662K ﹤0.01%
93,547
+67,705
+262% +$435K
2013 Q3
51 quarters
NPK icon
3659
National Presto Industries
NPK
$1.08B
$661K ﹤0.01%
5,287
+2,296
+77% +$311K
2013 Q2
52 quarters
IYM icon
3660
iShares US Basic Materials ETF
IYM
$1.27B
$659K ﹤0.01%
3,669
-96
-3% -$17.6K
2013 Q2
52 quarters
JBSS icon
3661
John B. Sanfilippo & Son
JBSS
$630M
$658K ﹤0.01%
7,648
+4,168
+120% +$330K
2013 Q2
52 quarters
ALLT icon
3662
Allot
ALLT
$408M
$657K ﹤0.01%
74,272
+18,804
+34% +$140K
2025 Q2
4 quarters
TFX icon
3663
Teleflex
TFX
$5.93B
$657K ﹤0.01%
5,184
-95,601
-95% -$12.2M
2013 Q2
52 quarters
RVLV icon
3664
Revolve Group
RVLV
$1.53B
$655K ﹤0.01%
28,614
+22,377
+359% +$495K
2019 Q4
26 quarters
LADR icon
3665
Ladder Capital
LADR
$1.15B
$654K ﹤0.01%
65,731
+47,598
+262% +$483K
2014 Q2
48 quarters
KLAR icon
3666
Klarna Group
KLAR
$5.01B
$654K ﹤0.01%
32,297
+21,447
+198% +$338K
2025 Q4
2 quarters
CIM icon
3667
Chimera Investment
CIM
$694M
$652K ﹤0.01%
48,900
-229,223
-82% -$3.07M
2013 Q2
52 quarters
XPEL icon
3668
XPEL
XPEL
$1.17B
$651K ﹤0.01%
13,130
+7,851
+149% +$358K
2019 Q3
27 quarters
AMTM icon
3669
Amentum Holdings
AMTM
$5.47B
$651K ﹤0.01%
31,486
-9,185
-23% -$222K
2024 Q3
7 quarters
GRDN icon
3670
Guardian Pharmacy Services
GRDN
$2.59B
$650K ﹤0.01%
15,515
+12,180
+365% +$472K
2024 Q4
6 quarters
PNTG icon
3671
Pennant Group
PNTG
$1.44B
$649K ﹤0.01%
17,555
+11,604
+195% +$379K
2019 Q4
26 quarters
BLFS icon
3672
DELISTED
BioLife Solutions
BLFS
$646K ﹤0.01%
22,859
+1,475
+7% +$34.5K
2019 Q1
29 quarters
DLO icon
3673
dLocal
DLO
$3.88B
$644K ﹤0.01%
49,574
-23,631
-32% -$300K
2021 Q2
20 quarters
ZVRA icon
3674
Zevra Therapeutics
ZVRA
$609M
$644K ﹤0.01%
44,923
+22,993
+105% +$256K
2021 Q2
20 quarters
EPC icon
3675
Edgewell Personal Care
EPC
$1.29B
$644K ﹤0.01%
23,974
-161,503
-87% -$3.45M
2013 Q2
52 quarters

Similar funds

Citigroup's Q2 2026 Portfolio in Review

As of Q2 2026, Citigroup held 6,442 positions worth $303B, up 29% from $235B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Citigroup deployed $27.6B of net new capital in Q2 2026, opening 555 new positions and adding to 3,283 existing holdings. Its largest new stake was Honeywell Aerospace: 579,875 shares worth $128M.

By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, down from 45% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.22B trimmed.

  • Citigroup's largest Q2 2026 buy was Honeywell Aerospace: 579,875 shares worth $128M.
  • Citigroup added most to NVIDIA in Q2 2026, an estimated $2.36B increase.
  • Citigroup's biggest Q2 2026 reduction was iShares Russell 2000 ETF, cutting an estimated $1.22B.
  • Citigroup fully exited Sealed Air in Q2 2026, selling an estimated $111M.
  • Citigroup's ten largest holdings make up 20% of its $303B portfolio in Q2 2026.
  • Citigroup opened 555 new positions and closed 760 in Q2 2026.
  • Citigroup's portfolio value rose 29% quarter-over-quarter to $303B.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.